MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
2.760
0.000
0.00%
Opening 11:45 09/11 EDT
OPEN
2.780
PREV CLOSE
2.760
HIGH
2.780
LOW
2.651
VOLUME
5.18K
TURNOVER
--
52 WEEK HIGH
34.60
52 WEEK LOW
2.610
MARKET CAP
3.81M
P/E (TTM)
-0.1269
1D
5D
1M
3M
1Y
5Y
1D
BioRestorative Therapies Faces Disputed Executive Resignation Claim
TipRanks · 5h ago
Weekly Report: what happened at BRTX last week (0831-0904)?
Weekly Report · 4d ago
Upcoming Stock Splits This Week (September 7 to September 11) – Stay Invested
TipRanks · 5d ago
BioRestorative Therapies Inc trading halted, news pending
TipRanks · 6d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 09/03 17:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/03 12:05
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Benzinga · 09/03 08:43
BioRestorative Therapies Announces Leadership and Governance Restructuring
TipRanks · 09/02 10:33
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.